

2 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Juxtapose Latitudes | December 2025 | Indefinite | $64M | 1 |
| NS Growth Investors VI | April 2025 | Indefinite | $682,000 | 12 |
| ND GROWTH INVESTORS IIIFiled to raise in 2024, with no closing reported yet. | 2024 | Indefinite | $0 | 0 |
| JUXTAPOSE VENTURES III | May 2023 | Indefinite | $240M | 44 |
| NOHO HOLDINGS III |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
2 partners are named across this firm’s filings, 2 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| Jed Cairo | Quiet | Healthcare services, Digital health, E-commerce & marketplaces | 5 |
Categories of Juxtapose’s own portfolio companies, based on 6 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Juxtapose’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Addition | 1 | Tend Dental |
| Goodwater | 1 | NoHo Health |
| Oak HC/FT | 1 | NoHo Wellness |
| Obvious Ventures | 1 |
| May 2023 |
| Indefinite |
| $18M |
| 36 |
| NS GROWTH INVESTORS V | 2023 | $2.3M | $2.3M | 3 |
| 0 |
| Patrick Chun | Quiet | Healthcare services, E-commerce & marketplaces, Fintech | 5 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| Nectar Life Sciences |
A shared board seat: a company where filings name a Juxtapose partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.